Broadfin is a U. S. based healthcare long-short hedge fund investing in the following sectors: Medical technology and supplies, biotechnology, pharmaceuticals and medical services. The team has over 20 years investing experience in the industry. Its strategy is to target superior absolute returns through intense research and a non-consensus, value based investing approach.

www.cantelmedical.com

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Its products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens.

www.hmstn.com

Healthcare Management Systems, Inc. was founded in 1984, the company develops, sells and supports integrated clinical and financial hospital information systems and services for the healthcare industry. Some of its products and services include: Financial and administrative software, Clinical software, Support and professional services and Software / Hardware implementation.

www.lifemasters.com

LifeMasters Supported SelfCare Inc is a leading US disease management company, providing programs and services for individuals living with chronic diseases to enable them to achieve optimum levels of health.  With over 600,000 participants, LifeMasters offers programs for patients with diabetes, congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, hypertension, asthma and musculo-skeletal pain. The company works with some of the US’s leading health plans, employers, retirement systems and governmental organizations.

www.monogrambio.com

Monogram Biosciences is a biotechnology company advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. Its products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. Monogram's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics.

www.prostrakan.com

ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the in-licensing, development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. The company’s current strategic focus is on the treatment of conditions related to women's health, the ageing male, and bone disease. ProStrakan is headquartered in Scotland and has commercial operations throughout the rest of the UK and continental Europe, employing approximately 200 people.